NHS National Pharmaceuticals Dasatinib and Paliperidone Injection
NHS England · Awarded
- Buyer
- NHS England
- Status
- Awarded
- Country
- United Kingdom
- Region
- England
- Sector
- Manufacturing
- Reference
- FaT-ocds-h6vhtk-03981f
- Published
- 2023-04-27
- Deadline
- 2026-04-21
Tender summary
Proposed framework agreement for NHS National Generic Pharmaceuticals Dasatinib and Paliperidone Injection. Offer reference number: CM/PHG/22/5694 Potential periods of call-offs under the framework agreement: CM/PHG/22/5694/00 - Dasatinib CESW 01/05/2023 – 30/04/2024 – (12 Months) LSNE 01/05/2023 – 30/04/2024 – (12 Months) NWLN 01/05/2023 – 30/04/2024 – (12 Months) CM/PHG/22/5694/01 - Paliperidone Injection: LSNE 01/05/2023 – 31/05/2024 (13 Months) NWLN 01/05/2023 – 31/01/2025 (21 months)
This is a public summary of a procurement notice. Dates and status reflect the notice held by BidScout; check the full notice before bidding.
Full tender details have a three-minute guest preview for open opportunities. AI insights require registration.
Register for full access